Clinical Trials Directory

Trials / Completed

CompletedNCT04710992

Influence of Percutaneous Electrolysis on Endogenous Pain Modulation

Influence of Percutaneous Electrolysis on Endogenous Pain Modulation: A Randomized Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
46 (actual)
Sponsor
University of Salamanca · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

Percutaneous electrolysis is a minimally invasive approach that consists in the application of a galvanic current through an acupuncture needle. Although several mechanisms and effects are attributed to percutaneous electrolysis, currently there are only a few publications that delve into this topic. The aim of this study is to investigate the influence of percutaneous electrolysis on the endogenous pain modulation. Four groups of intervention will be involved: no-intervention, isolated needling procedure, low intensity percutaneous electrolysis and high intensity percutaneous electrolysis. The effects on the pain modulation system will be evaluated before and immediately after the intervention, through pressure pain thresholds, conditioned pain modulation and temporal summation.

Conditions

Interventions

TypeNameDescription
PROCEDUREIsolated needling procedureThe needle will be inserted into the common extensor tendon of the epicondyle (dominant elbow) for 90 seconds without galvanic current.
PROCEDURELow intensity percutaneous electrolysisOnce the needle is located in the common extensor tendon of the epicondyle (dominant elbow), a single impact of galvanic current will be applied with an intensity of 0.3 mA for 90 seconds.
PROCEDUREHigh intensity percutaneous electrolysisThe needle will be inserted in the target position during the same time as in the other groups (90 seconds). During the first stage of intervention the needle will be imbedded without galvanic current and when the end of the application time approaches (approximately 75 seconds) three impacts of galvanic current will be applied with an intensity of 3 mA and a duration of 3 seconds each.

Timeline

Start date
2022-10-03
Primary completion
2022-12-23
Completion
2022-12-23
First posted
2021-01-15
Last updated
2023-01-26

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT04710992. Inclusion in this directory is not an endorsement.